They have demonstrated beneficial effects on metabolic parameters, reducing glycated haemoglobin (HbA1c), increasing insulin sensitivity and β-cell secretion, together with an improvement in inflammatory markers, in patients with T2DM [55,56] and with a history of myocardial infarction [57,58,59,60,61,62,63]. This evidence concerns the gene INS and myocardial infarction.